QuidelOrtho
QDEL
$55.86
Share price
-3.18%
Change (1 day)
-23.05%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.
Revenue for QuidelOrtho (QDEL)
Revenue in 2024 (TTM): A$4.23 Billion
According to QuidelOrtho's latest financial reports the company's current revenue (TTM 
) is A$4.39 Billion. an increase over the revenue in the year 2023 that were of A$4.40 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for QuidelOrtho from 1996 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | A$4.47 B | 1.68% |
| 2023 | A$4.40 B | -8.32% |
| 2022 | A$4.79 B | 104.84% |
| 2021 | A$2.34 B | 8.42% |
| 2020 | A$2.16 B | 182.86% |
| 2019 | A$0.76 B | 3.05% |
| 2018 | A$0.74 B | 108.39% |
| 2017 | A$0.35 B | 33.84% |
| 2016 | A$0.26 B | -1.27% |
| 2015 | A$0.26 B | 20.43% |
| 2014 | A$0.22 B | 13.68% |
| 2013 | A$0.19 B | 31.22% |
| 2012 | A$0.14 B | -3.11% |
| 2011 | A$0.15 B | 38.63% |
| 2010 | A$0.11 B | -38.99% |
| 2009 | A$0.18 B | 0.7% |
| 2008 | A$0.18 B | 34.49% |
| 2007 | A$0.13 B | 0.41% |
| 2006 | A$0.13 B | 6.61% |
| 2005 | A$0.12 B | 25.64% |
| 2004 | A$0.10 B | -21.53% |
| 2003 | A$0.12 B | -5.49% |
| 2002 | A$0.13 B | -5.6% |
| 2001 | A$0.14 B | 18.67% |
| 2000 | A$0.12 B | |
| 1998 | A$80.67 M | 16.03% |
| 1997 | A$69.53 M | 42.36% |
| 1996 | A$48.84 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | A$0.52 B | -88.03% | 🇺🇸 USA |
 | A$32.61 B | 641.67% | 🇺🇸 USA |
 | A$67.75 B | 1,440.80% | 🇺🇸 USA |
 | A$0.29 B | -93.32% | 🇺🇸 USA |
 | A$37.72 B | 757.92% | 🇺🇸 USA |
 | A$5.30 B | 20.65% | 🇺🇸 USA |